Latest Insider Transactions at Silverback Therapeutics, Inc. (SBTX)
This section provides a real-time view of insider transactions for Silverback Therapeutics, Inc. (SBTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silverback Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silverback Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2024
|
Kathleen D. Scott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-71.64%
|
$200,000
$16.0 P/Share
|
|
Oct 16
2024
|
Kathleen D. Scott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+41.74%
|
$12,500
$1.5 P/Share
|
|
Oct 15
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.39%
|
$1,400,000
$15.0 P/Share
|
|
Oct 15
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.39%
|
$1,400,000
$15.0 P/Share
|
|
Oct 08
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.58%
|
$1,300,000
$13.83 P/Share
|
|
Oct 08
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.58%
|
$1,300,000
$13.83 P/Share
|
|
Sep 18
2024
|
Eric Karas Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.72%
|
$140,000
$14.0 P/Share
|
|
Sep 18
2024
|
Eric Karas Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.92%
|
$10,000
$1.5 P/Share
|
|
Sep 17
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.4%
|
$1,200,000
$12.93 P/Share
|
|
Sep 17
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.4%
|
$1,200,000
$12.93 P/Share
|
|
Sep 10
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.4%
|
$1,100,000
$11.5 P/Share
|
|
Sep 10
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.4%
|
$1,100,000
$11.5 P/Share
|
|
Aug 26
2024
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
83,695
-100.0%
|
$1,088,035
$13.0 P/Share
|
|
Aug 26
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
83,695
-100.0%
|
$1,088,035
$13.0 P/Share
|
|
Aug 23
2024
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
69,500
-45.37%
|
$903,500
$13.03 P/Share
|
|
Aug 23
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
69,500
-45.37%
|
$903,500
$13.03 P/Share
|
|
Aug 22
2024
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
391,482
-71.87%
|
$4,697,784
$12.94 P/Share
|
|
Aug 22
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
391,482
-71.87%
|
$4,697,784
$12.94 P/Share
|
|
Aug 21
2024
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
407,700
-21.9%
|
$5,707,800
$14.07 P/Share
|
|
Aug 21
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
407,700
-21.9%
|
$5,707,800
$14.07 P/Share
|
|
Aug 20
2024
|
Kathleen D. Scott Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-48.64%
|
$200,000
$16.0 P/Share
|
|
Aug 20
2024
|
Kathleen D. Scott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+32.72%
|
$12,500
$1.5 P/Share
|
|
Aug 20
2024
|
Brian Dorsey Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-89.25%
|
$750,000
$15.0 P/Share
|
|
Aug 20
2024
|
Brian Dorsey Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+47.16%
|
$0
$0.64 P/Share
|
|
Aug 20
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-1.08%
|
$1,500,000
$15.54 P/Share
|
|
Aug 20
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-1.08%
|
$1,500,000
$15.54 P/Share
|
|
Aug 19
2024
|
Eric Karas Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.72%
|
$140,000
$14.0 P/Share
|
|
Aug 19
2024
|
Eric Karas Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.92%
|
$10,000
$1.5 P/Share
|
|
Aug 13
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-1.63%
|
$1,200,000
$12.27 P/Share
|
|
Aug 13
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-1.63%
|
$1,200,000
$12.27 P/Share
|
|
Aug 13
2024
|
Brian Dorsey Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-83.28%
|
$390,000
$13.0 P/Share
|
|
Aug 13
2024
|
Brian Dorsey Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+45.44%
|
$0
$0.64 P/Share
|
|
Jul 16
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.08%
|
$1,100,000
$11.4 P/Share
|
|
Jul 16
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.08%
|
$1,100,000
$11.4 P/Share
|
|
Jul 09
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-3.09%
|
$900,000
$9.62 P/Share
|
|
Jul 09
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-3.09%
|
$900,000
$9.62 P/Share
|
|
Jun 13
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,900
-57.5%
|
-
|
|
Jun 12
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
95,862
-2.88%
|
$862,758
$9.15 P/Share
|
|
Jun 12
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
95,862
-2.88%
|
$862,758
$9.15 P/Share
|
|
Jun 11
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
4,138
-0.12%
|
$37,242
$9.0 P/Share
|
|
Jun 11
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
4,138
-0.12%
|
$37,242
$9.0 P/Share
|
|
Jun 07
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,950
-21.65%
|
-
|
|
Jun 04
2024
|
Pratik Shah |
BUY
Bona fide gift
|
Indirect |
1,332,900
+50.0%
|
-
|
|
Jun 04
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,900
-17.79%
|
-
|
|
Jun 04
2024
|
Pratik Shah |
SELL
Other acquisition or disposition
|
Indirect |
2,665,800
-26.25%
|
-
|
|
May 16
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
89,096
-2.6%
|
$801,864
$9.06 P/Share
|
|
May 16
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
89,096
-2.6%
|
$801,864
$9.06 P/Share
|
|
May 15
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
5,147
-0.15%
|
$46,323
$9.05 P/Share
|
|
May 15
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
5,147
-0.15%
|
$46,323
$9.05 P/Share
|
|
May 14
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
5,757
-0.17%
|
$51,813
$9.01 P/Share
|